Geode Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Geode Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,178	Closed	-$158K	–	4951
2022 Q4	$158K	Sell	14,178 -140,993	-91%	-$1.37M	﹤0.01%	4214
2022 Q3	$872K	Buy	155,171 +33,231	+27%	+$208K	﹤0.01%	3460
2022 Q2	$528K	Sell	121,940 -83,500	-41%	-$475K	﹤0.01%	3732
2022 Q1	$2.39M	Buy	205,440 +4,006	+2%	+$47.7K	﹤0.01%	3172
2021 Q4	$3.68M	Buy	201,434 +16,537	+9%	+$210K	﹤0.01%	3063
2021 Q3	$2.19M	Sell	184,897 -26,998	-13%	-$393K	﹤0.01%	3307
2021 Q2	$3.64M	Buy	211,895 +49,493	+30%	+$941K	﹤0.01%	3078
2021 Q1	$2.97M	Buy	162,402 +28,836	+22%	+$605K	﹤0.01%	3062
2020 Q4	$2.51M	Buy	133,566 +20,849	+18%	+$450K	﹤0.01%	2959
2020 Q3	$2.38M	Buy	112,717 +193	+0.2%	+$4.51K	﹤0.01%	2784
2020 Q2	$3.25M	Buy	112,524 +20,995	+23%	+$633K	﹤0.01%	2564
2020 Q1	$3.2M	Buy	91,529 +21,038	+30%	+$681K	﹤0.01%	2413
2019 Q4	$1.72M	Buy	+70,491	New	+$1.24M	﹤0.01%	3077

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geode Capital Management's OYST Position: Q1 2023 in Review

Geode Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 14,178 shares — an estimated $158K sold.

Geode Capital Management first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $3.68M in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Geode Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Geode Capital Management sold 14,178 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $158K.
Geode Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
Geode Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $3.68M in Q4 2021.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.